Kangmei Pharmaceutical Co., Ltd. (SHA: 600518)
China flag China · Delayed Price · Currency is CNY
2.520
-0.140 (-5.26%)
Nov 13, 2024, 3:00 PM CST

Kangmei Pharmaceutical Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
34,93725,78730,50142,83913,33018,553
Upgrade
Market Cap Growth
10.75%-15.45%-28.80%221.38%-28.15%-59.50%
Upgrade
Enterprise Value
34,41324,90428,79776,02847,87854,483
Upgrade
Last Close Price
2.521.862.203.092.683.73
Upgrade
PE Ratio
136.72186.00-5.42--
Upgrade
Forward PE
-2.562.562.562.562.56
Upgrade
PS Ratio
6.705.297.3010.322.461.62
Upgrade
PB Ratio
4.963.644.374.30-1.280.90
Upgrade
P/TBV Ratio
4.414.004.834.64-1.20
Upgrade
P/FCF Ratio
---1006.1218.277.70
Upgrade
P/OCF Ratio
---199.9912.926.44
Upgrade
PEG Ratio
0.530.530.530.530.530.53
Upgrade
EV/Sales Ratio
6.605.116.8918.318.854.76
Upgrade
EV/EBITDA Ratio
57.3750.72----
Upgrade
EV/EBIT Ratio
123.95121.27----
Upgrade
EV/FCF Ratio
-68.45--1785.5965.6222.62
Upgrade
Debt / Equity Ratio
0.030.040.040.02-2.091.59
Upgrade
Debt / EBITDA Ratio
0.360.47----
Upgrade
Debt / FCF Ratio
---4.8229.7813.67
Upgrade
Asset Turnover
0.360.330.270.170.110.17
Upgrade
Inventory Turnover
1.601.541.260.911.570.32
Upgrade
Quick Ratio
0.770.860.821.000.540.54
Upgrade
Current Ratio
1.431.461.361.670.801.69
Upgrade
Return on Equity (ROE)
3.71%1.47%-31.78%--607.26%-19.91%
Upgrade
Return on Assets (ROA)
1.21%0.87%-4.16%-7.71%-34.20%-1.55%
Upgrade
Return on Capital (ROIC)
2.41%1.76%-7.46%-17.72%-51.60%-1.84%
Upgrade
Earnings Yield
0.73%0.40%-8.81%18.48%-233.20%-25.12%
Upgrade
FCF Yield
-1.44%-1.62%-2.62%0.10%5.47%12.98%
Upgrade
Payout Ratio
0.00%--0.17%--
Upgrade
Buyback Yield / Dilution
-0.03%27.54%-1.85%-0.55%-179.83%20.41%
Upgrade
Total Shareholder Return
-0.03%27.54%-1.85%-0.55%-179.83%20.41%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.